JD Bioscience

JD Bioscience (JDB) is

a Biopharma company established in 2017 focusing on small molecule-based novel drug development.

JD Bioscience was established by a team of highly experienced medicinal chemists, biologists, and clinicians in the field of endocrine and metabolic diseases.

Our therapeutic area is

mainly focused on metabolic diseases with high unmet medical needs.

Our main therapeutic sectors are metabolic diseases, especially inflammatory, fibrotic and cardiovascular diseases, and cancer.

Our goal is

to provide safe and effective therapies.

We aim to discover and develop first-in class drugs against novel targets for metabolic diseases to address the unmet medical needs, to provide a better quality of life for patients and their families.